Manufacturer
Allergan
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 86
- Molecules
- 37
- Therapy areas
- 8
Allergan is a pharmaceutical manufacturer based in United States. MedsAcross lists 86 of its products across 37 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Allergan, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Allergan products through licensed channels, with the documents your regulator needs.
Psychiatry
28 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Celexa 10 mg tabletOral | Citalopram | US FDA | Available on request |
| Celexa 20 mg tabletOral | Citalopram | US FDA | Available on request |
| Celexa 40 mg tabletOral | Citalopram | US FDA | Available on request |
| Lexapro 10 mg tabletOral | Escitalopram | US FDA | Available on request |
| Lexapro 20 mg tabletOral | Escitalopram | US FDA | Available on request |
| Lexapro 5 mg tabletOral | Escitalopram | US FDA | Available on request |
| Namzaric 10 mg/14 mg capsuleOral | Donepezil and Memantine | US FDA | Available on request |
| Namzaric 10 mg/21 mg capsuleOral | Donepezil and Memantine | US FDA | Available on request |
| Namzaric 10 mg/28 mg capsuleOral | Donepezil and Memantine | US FDA | Available on request |
| Namzaric 10 mg/7 mg capsuleOral | Donepezil and Memantine | US FDA | Available on request |
| Saphris 10 mg sublingual tabletSublingual | Asenapine | US FDA | Available on request |
| Saphris 2.5 mg sublingual tabletSublingual | Asenapine | US FDA | Available on request |
| Saphris 5 mg sublingual tabletSublingual | Asenapine | US FDA | Available on request |
| Savella kitOral | Milnacipran | US FDA | Available on request |
| Savella 100 mg tabletOral | Milnacipran | US FDA | Available on request |
| Savella 12.5 mg tabletOral | Milnacipran | US FDA | Available on request |
| Savella 25 mg tabletOral | Milnacipran | US FDA | Available on request |
| Savella 50 mg tabletOral | Milnacipran | US FDA | Available on request |
| Viibryd 10 mg tabletOral | Vilazodone | US FDA | Available on request |
| Viibryd 20 mg tabletOral | Vilazodone | US FDA | Available on request |
| Viibryd 40 mg tabletOral | Vilazodone | US FDA | Available on request |
| Vraylar kitOral | Cariprazine | US FDA | Available on request |
| Vraylar 0.5 mg capsuleOral | Cariprazine | US FDA | Available on request |
| Vraylar 0.75 mg capsuleOral | Cariprazine | US FDA | Available on request |
| Vraylar 1.5 mg capsuleOral | Cariprazine | US FDA | Available on request |
| Vraylar 3 mg capsuleOral | Cariprazine | US FDA | Available on request |
| Vraylar 4.5 mg capsuleOral | Cariprazine | US FDA | Available on request |
| Vraylar 6 mg capsuleOral | Cariprazine | US FDA | Available on request |
Cardiology
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bystolic 10 mg tabletOral | Nebivolol | US FDA | Available on request |
| Bystolic 2.5 mg tabletOral | Nebivolol | US FDA | Available on request |
| Bystolic 20 mg tabletOral | Nebivolol | US FDA | Available on request |
| Bystolic 5 mg tabletOral | Nebivolol | US FDA | Available on request |
| Fml 1 mg/mL ophthalmic suspensionOphthalmic | Fluorometholone | US FDA | Available on request |
| FML Forte 2.5 mg/mL ophthalmic suspensionOphthalmic | Fluorometholone | US FDA | Available on request |
| Ozurdex 0.7 mg implantIntravitreal | Dexamethasone | US FDA | Available on request |
| Pred Forte 10 mg/mL ophthalmic suspensionOphthalmic | Prednisolone | US FDA | Available on request |
| Pred Mild 1.2 mg/mL ophthalmic suspensionOphthalmic | Prednisolone | US FDA | Available on request |
| Rectiv 0.4% ointmentRectal | Nitroglycerin | US FDA | Available on request |
Gastroenterology
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Canasa 1000 mg suppositoryRectal Cold chain | Mesalamine | US FDA | Available on request |
| Carafate 1 g tabletOral | Sucralfate | US FDA | Available on request |
| Carafate 1 g/10 mL oral suspensionOral | Sucralfate | US FDA | Available on request |
| Linzess 145 mcg capsuleOral | Linaclotide | US FDA | Available on request |
| Linzess 290 mcg capsuleOral | Linaclotide | US FDA | Available on request |
| Linzess 72 mcg capsuleOral | Linaclotide | US FDA | Available on request |
| Urso 250 250 mg tabletOral | Ursodiol | US FDA | Available on request |
| Urso Forte 500 mg tabletOral | Ursodiol | US FDA | Available on request |
| Viberzi 100 mg tabletOral | Eluxadoline | US FDA | Available on request |
| Viberzi 75 mg tabletOral | Eluxadoline | US FDA | Available on request |
Ophthalmology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Alphagan P 1 mg/mL eye dropsOphthalmic | Brimonidine | US FDA | Available on request |
| Alphagan P 1.5 mg/mL eye dropsOphthalmic | Brimonidine | US FDA | Available on request |
| Durysta 10 mcg implantIntracameral Cold chain | Bimatoprost | US FDA | Available on request |
| Lastacaft 2.5 mg/mL eye dropsOphthalmic | Alcaftadine | US FDA | Available on request |
| Latisse 0.3 mg/mL eye dropsOphthalmic | Bimatoprost | US FDA | Available on request |
| Lumigan 0.1 mg/mL eye dropsOphthalmic | Bimatoprost | US FDA | Available on request |
Antibiotics
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Avycaz 0.5 g/2 g powder for injectionIntravenous | Avibactam and Ceftazidime | US FDA | Available on request |
| Dalvance 500 mg/25 mL powder for injectionIntravenous | Dalbavancin | US FDA | Available on request |
| Ocuflox 3 mg/mL eye dropsOphthalmic | Ofloxacin | US FDA | Available on request |
| Teflaro 400 mg/20 mL powder for injectionIntravenous | Ceftaroline fosamil | US FDA | Available on request |
| Teflaro 600 mg/20 mL powder for injectionIntravenous | Ceftaroline fosamil | US FDA | Available on request |
| Zymaxid 5 mg/mL eye dropsOphthalmic | Gatifloxacin | US FDA | Available on request |
Rheumatology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Acular 5 mg/mL eye dropsOphthalmic | Ketorolac | US FDA | Available on request |
| Acular LS 4 mg/mL eye dropsOphthalmic | Ketorolac | US FDA | Available on request |
| Acuvail 4.5 mg/mL eye dropsOphthalmic | Ketorolac | US FDA | Available on request |
Immunology and transplant
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Restasis 0.5 mg/mL ophthalmic emulsionOphthalmic | Cyclosporine | US FDA | Available on request |
| Restasis MultiDose 0.5 mg/mL ophthalmic emulsionOphthalmic | Cyclosporine | US FDA | Available on request |
Nephrology and urology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Oxytrol 3.9 mg/day transdermal patchTransdermal | Oxybutynin | US FDA | Available on request |
Other products
20 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Actonel 21 mg/129 mg tabletOral | Risedronate and Risedronate sodium hemipentahydrate | US FDA | Available on request |
| Actonel 4.9 mg/30.1 mg tabletOral | Risedronate and Risedronate sodium hemipentahydrate | US FDA | Available on request |
| Atelvia 4.9 mg/30.1 mg delayed-release tabletOral | Risedronate and Risedronate sodium hemipentahydrate | US FDA | Available on request |
| Botox 100 units powder for injectionIntradermal, intramuscular Cold chain | Botulinum toxin type a | US FDA | Available on request |
| Botox 200 units powder for injectionIntradermal, intramuscular Cold chain | Botulinum toxin type a | US FDA | Available on request |
| BOTOX Cosmetic 100 units powder for injectionIntramuscular Cold chain | Botulinum toxin type a | US FDA | Available on request |
| BOTOX Cosmetic 50 units powder for injectionIntramuscular Cold chain | Botulinum toxin type a | US FDA | Available on request |
| Combigan 2 mg/5 mg per mL eye dropsOphthalmic | Brimonidine and Timolol | US FDA | Available on request |
| Crinone 4% vaginal gelVaginal | Progesterone | US FDA | Available on request |
| Crinone 8% vaginal gelVaginal | Progesterone | US FDA | Available on request |
| Estrace 0.01% vaginal creamVaginal | Estradiol | US FDA | Available on request |
| Fetzima kitOral | Levomilnacipran | US FDA | Available on request |
| Fetzima 120 mg extended-release capsuleOral | Levomilnacipran | US FDA | Available on request |
| Fetzima 20 mg extended-release capsuleOral | Levomilnacipran | US FDA | Available on request |
| Fetzima 40 mg extended-release capsuleOral | Levomilnacipran | US FDA | Available on request |
| Fetzima 80 mg extended-release capsuleOral | Levomilnacipran | US FDA | Available on request |
| INFeD 100 mg/2 mL injectionIntramuscular, intravenous | Iron dextran | US FDA | Available on request |
| Liletta 52 mg intrauterine systemIntrauterine | Levonorgestrel | US FDA | Available on request |
| Ubrelvy 100 mg tabletOral | Ubrogepant | US FDA | Available on request |
| Ubrelvy 50 mg tabletOral | Ubrogepant | US FDA | Available on request |
Molecules made
Risedronate and Risedronate sodium hemipentahydrateKetorolacBrimonidineAvibactam and CeftazidimeBotulinum toxin type aNebivololMesalamineSucralfateCitalopramBrimonidine and TimololProgesteroneDalbavancinBimatoprostEstradiolLevomilnacipranFluorometholoneIron dextranAlcaftadineEscitalopramLevonorgestrelLinaclotideDonepezil and MemantineOfloxacinOxybutyninDexamethasonePrednisoloneNitroglycerinCyclosporineAsenapineMilnacipranCeftaroline fosamilUbrogepantUrsodiolEluxadolineVilazodoneCariprazineGatifloxacin
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Allergan
Send a request for any of these products. We confirm the licensed source, documents and lead time.